Eagle Health Investments’s Immunocore IMCR Stock Holding History

Eagle Health Investments’s Portfolio IMCR Stock Details IMCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.47M	Hold	46,300	–	–	0.24%	26
2026 Q1	$1.4M	Hold	46,300	–	–	0.24%	27
2025 Q4	$1.61M	Hold	46,300	–	–	0.35%	29
2025 Q3	$1.68M	Hold	46,300	–	–	0.44%	22
2025 Q2	$1.45M	Hold	46,300	–	–	0.36%	20
2025 Q1	$1.37M	Hold	46,300	–	–	0.36%	20
2024 Q4	$1.37M	Hold	46,300	–	–	0.33%	16
2024 Q3	$1.44M	Hold	46,300	–	–	0.27%	24
2024 Q2	$1.57M	Hold	46,300	–	–	0.28%	25
2024 Q1	$3.01M	Hold	46,300	–	–	0.56%	26
2023 Q4	$3.16M	Buy	+46,300	New	+$2.41M	0.64%	21

Other funds holding IMCR

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

VPC

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Eagle Health Investments's IMCR Position: Q2 2026 in Review

Eagle Health Investments held its Immunocore (IMCR) position steady in Q2 2026 at 46,300 shares worth $1.47M. The position accounts for 0.24% of the portfolio, ranked #26.

Eagle Health Investments first reported a position in IMCR in Q4 2023 and has held it in 11 quarters since. The position peaked at $3.16M in Q4 2023. 135 funds tracked by Wall St. Rank hold IMCR as of Q2 2026.

Eagle Health Investments held 46,300 shares of Immunocore worth $1.47M as of Q2 2026.
Eagle Health Investments left its Immunocore share count unchanged in Q2 2026.
Immunocore made up 0.24% of Eagle Health Investments's portfolio in Q2 2026, its #26 holding.
Eagle Health Investments first reported a position in Immunocore in Q4 2023 and has held it in 11 quarters since.
Eagle Health Investments's Immunocore position peaked at $3.16M in Q4 2023.
135 funds tracked by Wall St. Rank held Immunocore as of Q2 2026.

Based on Eagle Health Investments's 13F filing for Q2 2026, filed 10 Aug 2026.